Pargluva Effect: Bristol Foresees More Independent Scrutiny Of Trial Data

Greater availability of clinical trial data through online databases could lead to more independent reviews of study results akin to a published analysis of Pargluva data, Bristol-Myers Squibb U.S. Pharmaceuticals President Anthony Hooper speculated during a press meeting Nov. 18